EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 41 / No 5 (Mai 2025) Med Sci (Paris), 41 5 (2025) 460-468 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 5, Mai 2025
Enjeux et objectifs de la psychiatrie de précision
Page(s) 460 - 468
Section La psychiatrie de précision (PEPR PROPSY) : hypothèses et outils
DOI https://doi.org/10.1051/medsci/2025066
Published online 26 May 2025
  1. Oquendo MA, Wall M, Wang S, et al. Lifetime suicide attempts in otherwise psychiatrically healthy individuals. JAMA Psychiatry 2024 ; 81 : 572–8. [CrossRef] [PubMed] [Google Scholar]
  2. Oquendo MA, Galfalvy HC, Choo TH, et al. Occurrence and characteristics of suicidal ideation in psychiatrically healthy individuals based on ecological momentary assessment. Mol Psychiatry 2024 ; 29 : 3356–63. [CrossRef] [PubMed] [Google Scholar]
  3. John Mann J, Rizk MM. A brain-centric model of suicidal behavior. Am J Psychiatry 2020 ; 177 : 902–16. [CrossRef] [PubMed] [Google Scholar]
  4. Kendler KS, Ohlsson H, Mościcki EK, et al. Genetic liability to suicide attempt, suicide death, and psychiatric and substance use disorders on the risk for suicide attempt and suicide death: a Swedish national study. Psychol Med 2023 ; 53 : 1639–48. [CrossRef] [PubMed] [Google Scholar]
  5. Docherty AR, Mullins N, Ashley-Koch AE, et al. GWAS meta-analysis of suicide attempt: identification of 12 genome-wide significant loci and implication of genetic risks for specific health factors. Am J Psychiatry 2023 ; 180 : 723–38. [CrossRef] [PubMed] [Google Scholar]
  6. Campbell-Sills L, Sun X, Papini S, et al. Genetic, environmental, and behavioral correlates of lifetime suicide attempt: Analysis of additive and interactive effects in two cohorts of US Army soldiers. Neuropsychopharmacology 2023 ; 48 : 1623–9. [CrossRef] [PubMed] [Google Scholar]
  7. Parade SH, Huffhines L, Daniels TE, et al. A systematic review of childhood maltreatment and DNA methylation: candidate gene and epigenome-wide approaches. Transl Psychiatry 2021 ; 11 : 1–33. [CrossRef] [PubMed] [Google Scholar]
  8. Lepeule J, Broséus L, Jedynak P, et al. Expositions environnementales et modifications de l’épigénome dans la période des 1000 premiers jours de vie. Med Sci (Paris) 2024 ; 40 : 947–54. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. Underwood MD, Bakalian MJ, Escobar T, et al. Early-life adversity, but not suicide, is associated with less prefrontal cortex gray matter in adulthood. Int J Neuropsychopharmacol 2019 ; 22 : 349–57. [CrossRef] [PubMed] [Google Scholar]
  10. Lengvenyte A, Sundaresh A, Strumila R, et al. Combined effects of nitric oxide synthase 3 genetic variant and childhood emotional abuse on earlier onset of suicidal behaviours. Prog Neuropsychopharmacol Biol Psychiatry 2022 ; 119 : 110617. [CrossRef] [PubMed] [Google Scholar]
  11. Bhagar R, Gill SS, Le-Niculescu H, et al. Next-generation precision medicine for suicidality prevention. Transl Psychiatry 2024 ; 14 : 1–29. [CrossRef] [PubMed] [Google Scholar]
  12. Serafini G, Parisi VM, Aguglia A, et al. A specific inflammatory profile underlying suicide risk? Systematic review of the main literature findings. Int J Environ Res Public Health 2020 ; 17 : 2392. [Google Scholar]
  13. Herzog S, Bartlett EA, Zanderigo F, et al. Neuroinflammation, stress-related suicidal ideation, and negative mood in depression. JAMA Psychiatry 2025 ; 82 : 85–93. [CrossRef] [PubMed] [Google Scholar]
  14. Neupane SP, Daray FM, Ballard ED, et al. Immune-related biomarkers and suicidal behaviors: a meta-analysis. Eur Neuropsychopharmacology 2023 ; 75 : 15–30. [CrossRef] [Google Scholar]
  15. Lengvenyte A, Sebti E, Courtet P. Towards better understanding of the link between inflammation and suicidal ideation and behaviors. Minerva Psychiatry 2022 ; 63 : 397–406. [CrossRef] [Google Scholar]
  16. Lengvenyte A, Belzeaux R, Olié E, et al. Associations of potential plasma biomarkers with suicide attempt history, current suicidal ideation and subsequent suicidal events in patients with depression: A discovery study. Brain Behav Immun 2023 ; 114 : 242–54. [CrossRef] [PubMed] [Google Scholar]
  17. Velasco A, Lengvenyte A, Rodriguez-Revuelta J, et al. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in depressed patients with suicidal behavior: a systematic review. Eur Psychiatry 2023 ; 16 : 1–25. [Google Scholar]
  18. Sun S, Liu Q, Wang Z, et al. Brain and blood transcriptome profiles delineate common genetic pathways across suicidal ideation and suicide. Mol Psychiatry 2024 ; 29 : 1417–26. [CrossRef] [PubMed] [Google Scholar]
  19. Mann JJ, Huang YY, Underwood MD, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000 ; 57 : 729–38. [CrossRef] [PubMed] [Google Scholar]
  20. Underwood MD, Kassir SA, Bakalian MJ, et al. Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity. Transl Psychiatry 2018 ; 8 : 279. [CrossRef] [PubMed] [Google Scholar]
  21. Herzog S, Galfalvy H, Keilp JG, et al. Relationship of stress-reactive cortisol to suicidal intent of prior attempts in major depression. Psychiatry Res 2023 ; 327 : 115315. [CrossRef] [PubMed] [Google Scholar]
  22. Strumila R, Lengvenyte A, Zdanavicius L, et al. Higher levels of plasma Adrenocorticotropic hormone (ACTH) are associated with lower suicidal ideation in depressed patients compared to controls and suicide attempters, independently from depression severity. Compr Psychoneuroendocrinol 2024 ; 19 : 100235. [CrossRef] [PubMed] [Google Scholar]
  23. Spaan P, Verrijp T, Michielsen PJS, et al. The dexamethasone suppression test as a biomarker for suicidal behavior: a systematic review and meta-analysis. J Affect Disord 2025 ; 368 : 237–48. [CrossRef] [PubMed] [Google Scholar]
  24. Pandey GN, Rizavi HS, Zhang H, et al. The expression of the suicide-associated gene SKA2 is decreased in the prefrontal cortex of suicide victims but not of nonsuicidal patients. Int J Neuropsychopharmacol 2016 ; 19 : pyw015. [CrossRef] [PubMed] [Google Scholar]
  25. Alacreu-Crespo A, Hidalgo V, Girod C, et al. The impulsiveness level influences the salivary cortisol response and social stress sensitivity in suicidal patients. J Psychiatr Res 2022 ; 156 : 159–67. [CrossRef] [PubMed] [Google Scholar]
  26. Li H, Zhang X, Sun Q, et al. Association between serum lipid concentrations and attempted suicide in patients with major depressive disorder: a meta-analysis. PLoS One 2020 ; 15 : e0243847. [CrossRef] [PubMed] [Google Scholar]
  27. Knowles EEM, Curran JE, Meikle PJ, et al. Disentangling the genetic overlap between cholesterol and suicide risk. Neuropsychopharmacology 2018 ; 43 : 2556–63. [CrossRef] [PubMed] [Google Scholar]
  28. Bai S, Fang L, Xie J, et al. Potential biomarkers for diagnosing major depressive disorder patients with suicidal ideation. J Inflamm Res 2021 ; 14 : 495–503. [CrossRef] [Google Scholar]
  29. Schmaal L, Harmelen AL van, Chatzi V, et al. Imaging suicidal thoughts and behaviors: a comprehensive review of 2 decades of neuroimaging studies. Mol Psychiatry 2020 ; 25 : 408–27. [CrossRef] [PubMed] [Google Scholar]
  30. Bryant RA, Breukelaar IA, Williamson T, et al. The neural connectome of suicidality in adults with mood and anxiety disorders. Nat Ment Health 2024 ; 2 : 1342–9. [CrossRef] [Google Scholar]
  31. Ho TC, Walker JC, Teresi GI, et al. Default mode and salience network alterations in suicidal and non-suicidal self-injurious thoughts and behaviors in adolescents with depression. Transl Psychiatry 2021 ; 11 : 38. [CrossRef] [PubMed] [Google Scholar]
  32. Walsh CP, Bovbjerg DH, Marsland AL. Glucocorticoid resistance and β2-adrenergic receptor signaling pathways promote peripheral pro-inflammatory conditions associated with chronic psychological stress: a systematic review across species. Neurosci Biobehav Rev 2021 ; 128 : 117–35. [CrossRef] [PubMed] [Google Scholar]
  33. Dudek KA, Dion-Albert L, Lebel M, et al. Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression. Proc Natl Acad Sci USA 2020 ; 117 : 3326–36. [CrossRef] [PubMed] [Google Scholar]
  34. Duman RS, Deyama S, Fogaça MV. Role of BDNF in the pathophysiology and treatment of depression: activity-dependent effects distinguish rapid-acting antidepressants. Eur J Neurosci 2021 ; 53 : 126–39. [CrossRef] [PubMed] [Google Scholar]
  35. Fitzgerald PJ, Yen JY, Watson BO. Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test. PLoS One 2019 ; 14 : e0215554. [CrossRef] [PubMed] [Google Scholar]
  36. Sanchís-Ollé M, Fuentes S, Úbeda-Contreras J, et al. Controllability affects endocrine response of adolescent male rats to stress as well as impulsivity and behavioral flexibility during adulthood. Sci Rep 2019 ; 9 : 3180. [CrossRef] [PubMed] [Google Scholar]
  37. Lamontagne SJ, Wash SIJ, Irwin SH, et al. Effects of dopamine modulation on chronic stress-induced deficits in reward learning. Cogn Affect Behav Neurosci 2022 ; 22 : 736–53. [CrossRef] [PubMed] [Google Scholar]
  38. Luc OT, Kangas BD. Validation of a touchscreen probabilistic reward task for mice: a reverse-translated assay with cross-species continuity. Cogn Affect Behav Neurosci 2024 ; 24 : 281–8. [CrossRef] [PubMed] [Google Scholar]
  39. Courtet P, Nobile B, Olié É. Soyons plus ambitieux pour traiter le suicide. Med Sci (Paris) 2020 ; 36 : 1207–12. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  40. Del Matto L, Muscas M, Murru A, et al. Lithium and suicide prevention in mood disorders and in the general population: a systematic review. Neurosci Biobehav Rev 2020 ; 116 : 142–53. [CrossRef] [PubMed] [Google Scholar]
  41. Desfossés CY, Blier P. Les propriétés antidépressives de la kétamine: une revue. Med Sci (Paris) 2021 ; 37 : 27–34. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  42. Lengvenyte A, Olié E, Courtet P. Suicide has many faces, so does ketamine: a narrative review on ketamine’s antisuicidal actions. Curr Psychiatry Rep 2019 ; 21: 132. [CrossRef] [PubMed] [Google Scholar]
  43. Taipale H, Lähteenvuo M, Tanskanen A, et al. Comparative effectiveness of antipsychotics for risk of attempted or completed suicide among persons with schizophrenia. Schizophr Bull 2021 ; 47 : 23–30. [CrossRef] [PubMed] [Google Scholar]
  44. Andersson P, Lundberg J, Jarbin H, et al. Inverse association of anti-inflammatory prescription fills and suicide-related mortality in young adults: evidence from a nationwide study of Swedish regions, 2006-2021. Brain Behav Immun Health 2023 ; 31 : 100665. [CrossRef] [PubMed] [Google Scholar]
  45. Guo Y, Xia M, Ye R, et al. Electroconvulsive therapy regulates brain connectome dynamics in patients with major depressive disorder. Biol Psychiatry 2024 ; 96 : 929–39. [CrossRef] [PubMed] [Google Scholar]
  46. Li B, Zhao N, Tang N, et al. Targeting suicidal ideation in major depressive disorder with MRI-navigated Stanford accelerated intelligent neuromodulation therapy. Transl Psychiatry 2024 ; 14 : 21. [CrossRef] [PubMed] [Google Scholar]
  47. Posner K, Brown GK, Stanley B, et al. The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 2011 ; 168 : 1266–77. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.